Pioneer of executive search celebrates 75 years of growth, resilience and excellence in client service NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) — Boyden, a premier leadership and talent advisory firm with more than 75 offices in over 45 countries,
Appoints APAC Senior Director for Distribution MELBOURNE, Australia, July 21, 2021 (GLOBE NEWSWIRE) — Cradlepoint, a global leader in cloud-delivered 4G and 5G wireless network edge solutions, today announced a distribution partnership with Tech Data in Southeast Asia. The distribution
Align to reinforce its commitment to comprehensive dentistry by showcasing the Align Digital Platform, including recent innovations, in a multi-media exhibition space of hybrid in-person and virtual experiences TEMPE, Ariz. and COLOGNE, Germany and ROTKREUZ, Switzerland, July 20, 2021 (GLOBE
PHOENIX, July 20, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corporation (Nasdaq: WSC) today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021 after the markets close. Chief Executive Officer, Brad Soultz
Financing led by AXA IM’s Impact Investing strategy LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced
A better cost-effective option is now available for dietary supplement, functional food, and beverage manufacturers. Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) — Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of
LONDON, July 20, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, has announced that UK-headquartered Halfords, a leading automotive products and services retailer, is using Descartes’ last mile delivery solution
SHANGHAI, China, July 20, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has established a joint venture with
